Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia Meeting Abstract
| Authors: | Bewersdorf, J. P.; Patel, K. K.; Goshua, G.; Shallis, R. M.; Podoltsev, N. A.; Stahl, M. F.; Stempel, J. M.; Stein, E.; Huntington, S. F.; Zeidan, A. M. |
| Abstract Title: | Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 319 |
| End Page: | 321 |
| Language: | English |
| ACCESSION: | WOS:000893223200131 |
| DOI: | 10.1182/blood-2022-158465 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
